Thesis. Invalidation. Catalyst. Per ticker.

[position redacted] [position redacted] held into TODAY's (6/4) binary Q1 FY27 print; engine already [trade redacted] pre-print. Space-cluster theme now MATURING→edge-of-SATURATED (UFO ETF $1B AUM, NASA-ETF mania) with the ~6/12 SpaceX…

Solar-EBOS name traded as a 2nd-order AI-power play; early-May analyst cluster + Tennessee BESS facility lit the leg, now ~1 month stale with no catalyst until the ~early-August Q2 print. Range-bound $9.50–10; HOLD above the breakout base,…

Optical/photonics-transceiver leader survived its ~2026-05-08 Q1 print and ran to 400%+ YTD, but the theme has flipped ACCELERATING→SATURATED: dedicated photonics ETF launched (2026-05-13), MEME/leveraged-ETF retail flows, record $1.3T…

Data-center grid-power pick-and-shovel; backlog +40% YoY to ~$280M, Q4 orders ~$100M. But 2026-05-28 beat sold off on soft Q1 margin guide ($0.17 adj vs $0.24 est) — gapped ~9%, then -8.8% on Jun 3 to $46.67. Narrative accelerating, price…

Earnings binary resolved bullish (Q1 sales $616M vs $495M est, EPS $0.34 beat, 2026-05-05) but the tape SOLD it — topped $135.24, bled ~23% to ~$104. Theme downgraded ACCELERATING→MATURING as spot rolls to $84.70/lb (-2.8% MoM). 2026-06-01…

Nuclear-baseload-for-AI narrative has gone mainstream and CEG is the crowded, mature leg: Q1 beat (2026-05-11) sold off ~3%, Third Point fully exited, and an 11M-share secondary priced at $281 (2026-06-01) caps the tape with supply…

1.5–2.5x BTC-beta proxy in a confirmed bear leg, not a dip: BTC $63.6K (−50% off ATH, 11-day ETF outflows −$3.45B, MSTR now SELLING, whale distribution at 2022 lows). COIN $173.99 has sliced under the Piper $180 bear anchor and all MAs.…

Q1 binary resolved (beat-and-fade, mean-reverted $130s→~$104); now a choppy basing/recovery on fresh catalysts — Vera Rubin first-validation (6/1), BNP $192 initiation (6/2), NVDA stake. Earnings now Aug 11, so binary-risk DEFER reason is…

AI-PC + agentic-CPU + foundry-turnaround leg now CONTESTED: NVIDIA''s 2026-06-01 ARM AI-PC chip launch hit INTC -5% (direct x86 threat) while Burry shorts the semi complex on a dot-com parallel. Parabolic ~$102 (~170% above 200DMA, 108x…

Binary resolved: the £81m MACOM-led strategic raise (28 May 2026, 19.8p) killed the going-concern/dilution overhang and flipped the story from dying handset-epi to InP-for-AI-datacenter optical — Photonics +15%, FY2026 guided >20% growth +…

The flywheel REVERSED. Strategy went from perpetual BTC buyer to net SELLER (Saylor dumped, 6/1) and the STRC financing engine is in a "death spiral" (Schiff 6/2). BTC in "purge mode" below $67K (6/3) heading toward $50K. This is a…

NRC formally accepted the Kronos construction-permit app (5/20, +10.7%) and the SMCI AI-power MOU plug NNE into the nuclear-powers-AI meta-narrative — but the $400M ATM is now LIVE ($569M liquidity) and 6/03 faded 14% off $30.62 to close…

Nuclear-for-AI-power narrative MATURING, not accelerating. Q1 (5/13) print made OKLO a top-10 large-cap loser; DOE plutonium win (5/26) bounced it (Goldman $66, Cantor $122); then 2026-06-03 co-founders sold $13.6M and the stock dropped…

Government-bet leg ($2B CHIPS / $100M Commerce LOI, 5/21) is now DIGESTED, not fresh. Sell-side caught up with triple $40 PTs (6/2), QTUM ETF hit $5B = mainstream, short interest spiking, Quantinuum IPO (6/3) adds equity supply. Theme…

Quantum theme MATURING after the 2026-05-21 $2B CHIPS blow-off — and QUBT was NOT one of the 9 funded names. Faded to ~$11.34 (off $25.84 52w high), May-12 200-DMA reclaim failing. Quantinuum's $14.3B IPO (~2026-06-05) drains capital to…

Government-stake leg (2026-05-21 $2B CHIPS quantum push) already fired and cooled inside 4 sessions; theme tipping MATURING→SATURATED (QTUM ETF $5B AUM, short interest spiking, insider selling, IBM $10B + Quantinuum $14.3B IPO…

Beaten-down SMR re-activated on a NEW binary: South Korea''s $200B US-investment package is eyeing NuScale''s Tennessee/TVA program (Doosan + Samsung C&T in talks). But the tape is pure rip-fade (+9% 6/2 → −13% 6/3 to $12.13), fundamentals…

Optimus/robotics leg is actively breaking, not accelerating — TSLA shed $75B in a session on 2026-06-02 after Sam Altman targeted Optimus and NVIDIA armed Chinese humanoid rivals with an open robotics platform. Musk-complex capital is…

AI-optical/glass picks-and-shovels narrative has gone fully public — Mizuho PT $220 (5/12), photonics ETF launch (5/13), Cathie Wood "blasts from the past" (5/11) = saturation tell, not an entry. [trade redacted] on the 5/19 buy-the-news…

Crypto-financials leg broke — [trade redacted] chasing the BTC>$80k move above Cantor's $30 PT. Now a 265.1M-share offering/registration (5/21), a $100M BitGo claim (5/21), and Novogratz himself warning of a market top (5/26) = structural…

Rare-earth supply-security story is MATURING, not accelerating: structural floor intact (DoD price floor, Apple offtake, Texas magnet capex) but the momentum edge is spent — sell-side is now INITIATING (Goldman + Needham $81, both…

Hyperliquid proxy: fresh institutional narrative leg (ICE CEO "bigger than Nasdaq" 5/29, Hayes $100k bet 6/2) but [trade redacted] chasing the retail leg. Crypto rolled over (BTC <$68k) and a 35M-share secondary overhangs. WATCH not a buy…

[trade redacted] a week ago (entry [entry redacted] → [entry redacted]) on an exhaustion breakout. Broad AI-chip theme still ACCELERATING (fresh records 6/02), but QCOM''s own leg is MATURING/late: now spiking up retail most-searched…

Q1 binary resolved bullish (rev $200.3M, $2.2B backlog) but the trade morphed: a $3B ATM filed 5/20 caps every rally and the bid is now hot-money SpaceX-IPO proxy flow (UFO ETF $1B AUM, Bitcoin→space rotation 6/04). Theme…

Misclassified "AI-momentum" name — actually a money-losing B2B coffee roaster that [trade redacted] chasing RSI ~77 on sub-1x volume. No accelerating narrative now; only edge is a slow insider cluster + Benchmark $10 PT. Dead tape until Q2…

Iran-war crude premium that drove our May spike has fully unwound on the truce — oil-geo theme DEAD with no replacement catalyst. WTI back to dead-tape sub-$5 Gulf E&P with no momentum leg. SKIP / probe-only until a fresh dated catalyst…

Aluminum structural-deficit narrative (Hormuz/Mideast smelter disruption) has gone fully mainstream — UBS Buy $80 (05-22) and WF OW $70 (05-07) upgrades are done, CNBC 'Final Trades' named AA 3+ sessions through 2026-06-02, and there's…

[Stage 1 WATCH] RSI 75 with negative -95% Stocktwits velocity and no dossier; SHLS carries the industrial-power cluster cleaner today — consistent with three prior WATCH calls.

[Stage 1 DEFER] Theme ai-mag7 MATURING + edge +6.7pp barely passes 5pp floor + RSI 82.5 parabolic quarter-credit + $4T mega-cap dilutes alpha on $5k book

Busted-platform turnaround: ABCL re-rated ~74% in 90d off the $2.09 low on ABCL635 Phase 1 success + Q1 revenue beat (+98% YoY) + clustered upgrades. The Q3 2026 ABCL635 Phase 2 VMS topline is the binary that re-rates it — but it''s months…

Cannabis-reschedule sentiment beta — but ACB is the WRONG horse: a Canadian LP with zero U.S. THC ops, so the April 24 Schedule-III/280E catalyst doesn''t accrue. Sitting near 52wk low ($3.46 vs $6.67 high); June 11 earnings + June 29 DEA…

Broken-chart specialty-healthcare rehab story. UBS reiterated Buy + PT $31 on 2026-04-17, but single-analyst blip vs. multi-quarter downtrend + unresolved DOJ overhang. No narrative velocity — DORMANT. Wait for weekly 20-EMA reclaim on…

Post-ADVA legacy pivot + BEAD-fiber tailwind. Evercore's 2026-04-14 Outperform/$18 is the first constructive major-broker note in two years, but the trade is binary on the ~2026-05-07 Q1 print — need GM% ≥34% and book-to-bill >1.0 to…

BNPL narrative MATURING into consumer-credit stress cycle; Citizens cut PT to $85 on 2026-04-17 signaling sell-side decelerating. Next binary is Q3 FY26 print ~2026-05-08 — GMV growth and 30+ delinquency rate decide whether this is a fresh…

[Stage 1 WATCH] Arteris royalty re-accel, rule 4 fires (1.58x vol), RSI 66 healthy, small-float — valid but correlated into the AI-chip cluster already anchored by held TSM/NVDA.

[Stage 1 WATCH] Cyber ACCEL theme but rule_3 fails (not within 10% 52w high) and retail velocity -4% — FROG cleaner expression but also untradeable, theme covered

[Stage 1 WATCH] AI-chip-infra-memory cohort duplicate of TSM but no dossier, RSI 75.9 extended, rule 3 fails — TSM wins the slot in this theme cluster.

ALRIB = Riber S.A. (EPA:ALRIB), French MBE tool maker. ROSIE silicon-photonics/BTO platform narrative accelerating (+270% 6mo, US + Japan orders Sep-25/Jan-26), BUT no US ADR/OTC → untradable on Alpaca. Use as theme card for US cousins…

Sub-$2 ethanol / specialty-alcohol washout with DEAD narrative — no flow, no re-rating, no retail velocity. Strictly archetype-5 binary on the ~2026-05-07 Q1 print or an intra-quarter 8-K step-function (Pekin sale, JV, refi). 3-day…

[Stage 1 WATCH] small-cap-ai ACCEL but RSI 88.5 extreme (most parabolic), thin recent-IPO float, no dossier — chasing parabolic blind, deferred 4x; cleaner cluster names exist.

Archetype-6 squeeze vehicle in a whipsaw range: 2026-04-22 surge follows a -8% day and a failed 2026-04-17 CEO-hype rally. No retail-flow confirmation, no GME co-move. Earnings ~2026-05-05 is binary with a dilution tail. Default SKIP; only…

[Stage 1 WATCH] YieldMax AMD options-overlay ETF — covered-call structure caps upside on the exact narrative-momentum leg we want; AMD direct exposure preferred, not in candidate set today.

Picks-and-shovels AI-packaging play (#2 global OSAT, Arizona CHIPS-Act fab + Apple multi-year deal) but narrative is MATURING not accelerating, OSAT margin structure caps re-rating, and Q1 '26 earnings are inside the 3–10 trading-day…

Beaten-down healthcare-staffing cyclical. Q1 (5/07) EPS $2.10 crushed $1.62 est, but Q2 revenue guide $620-635M came in light vs $634.9M consensus and sell-side stayed mostly Neutral (PTs $26-32). No accelerating narrative — this is a…

2x-leveraged AMD wrapper sitting on an 11-day parabolic run (longest since 2005) into a binary Q1 print on 2026-04-30. Narrative real (MI400/OpenAI/Meta) but every beginner-trap flag is on: RSI>75, 18% stretched above 20-EMA underlying,…

AMZU = Direxion Daily AMZN Bull 2X leveraged ETF. Thesis is just "2x-expression of AMZN's AI/AWS narrative into the Q1 2026 print (~late-April/early-May)". Theme-tag "M&A/activism/special-sits" is a discovery-engine mis-label — flag and…

No trade — complete data vacuum. AMZZ tagged into m-and-a-activism-special-sits bucket on 2026-04-20 but zero headlines, zero filings, zero price context. Dormant until a 13D, definitive merger agreement, or tender offer surfaces.…

[Stage 1 PRIORITIZE] Outpacing SGMT in same biotech-precision theme (+57pp vs +51pp, momentum top 1%); fresh untested name — Stage 2 should decide whether to add or rotate from SGMT.

Power-discrete AI-content second-derivative play; B. Riley PT raise to $25 (2026-04-13) + two-session momentum tape (2026-04-14, 2026-04-20) = narrative discovery phase into FY26 Q3 print (~2026-05-06). Binary on earnings; no confirmed AI…

Pure-play next-gen Dupixent disruptor with half-life-extended IL-13/IL-4Rα/OX40L antibodies; APG777 Part B dose-optimization data in atopic dermatitis is the next binary. DORMANT — framework-ready, not actively in play without fresh price…

Biogen-deal re-rating (2026-04-06) already digested; Wells Fargo Equal-Weight at $41 PT (2026-04-17) caps upside. Next impulse is binary on ~2026-05-06 Q1 print — Syfovre net revs + Empaveli C3G ramp. MATURING, not ACCELERATING. Watch-only.

[Stage 1 WATCH] OSAT chip proxy, 5 rules, but rule 10=0 (not in any registry theme today), ~104% above 200-DMA, P/E 53, Nvidia-Halo trade gone mainstream — extended/late with no cluster confirm.

Consolidated-psychedelic-leader narrative (AtaiBeckley merger + 22.4% Compass stake, both COMP360 Phase 3 trials positive, BPL-003 EOP2 cleared) has ALREADY fired. Tape rolled from [entry redacted] to $4.53 with no hard data catalyst until…

Sell-side narrative just fractured: Sidoti downgrade to $24 on 2026-04-20 directly contradicts Mizuho's $27 raise from 2026-04-14. Mixed-signal regime into Q1 print (~2026-05-07) kills directional edge — DORMANT, no entry pre-earnings.

[Stage 1 WATCH] Korea-Asia semi-beta fresh theme conf 0.70; RSI 71.9 healthy + Stocktwits +100% but no dossier yet — wait for setup development and theme confirmation

Aerospace/defense materials supercycle picks-and-shovels — ATI titanium/superalloys into the jet-engine + airframe build. Stock ripped +11% to a new ATH ($183.30) post Q1 beat-and-raise, but now trades AT consensus PT (~$179.56) with no…

[Stage 1 WATCH] industrial-power-AI tag but cheap commodity cyclical, sell-side Neutral, price above avg PT, historically ~15% wide spread — chasing a +11% spike is poor R/R.

Gold-producer re-rate on $3,200+ spot + Era Dorada growth leg, but 2026-04-14 CAPEX hike to $386–463M (+65% mid) is an overhang into Q1 print (~2026-05-13). Probe only — wait for AISC and FCF guide.

[Stage 1 PRIORITIZE] NEW autonomous theme ACCEL conf 0.72 — McLane Berkshire-Hathaway driverless freight live in TX, Needham $13 PT, RSI 82 parabolic but fresh structural catalyst

2x daily-leveraged ETF on Broadcom (AVGO), not a stock. Custom-silicon hyperscaler-ASIC narrative is MATURING (AVGX +195% TTM). Only a tactical tool for short-window catalyst trades into AVGO Q2 FY26 print (~2026-06-05 est.). Leveraged-ETF…

Unidentified small-cap in commodity-materials basket; likely Avalon Advanced Materials (TSX:AVL) rare-earth/lithium play, but ticker-specific data (price, ADV, filings, catalysts) still absent as of 2026-04-20. DORMANT until first verified…

AVNS agreed 2026-04-14 to go private at $1.272B all-cash to American Industrial Partners — narrative is DEAD and replaced by merger-arb pin. No momentum trade here; tape will flatline into close. Skip for our playbook.

Structural-heart disruptor de-risking on PARADIGM pivotal milestones (first US patients 5/5, CMS coverage 4/28, Medtronic stake, Barclays PT $18). But +448% YoY into a $250M TD Cowen ATM at ~$9 = live dilution ceiling, stock pinned on the…

Thesis remains intact — industrial-power-ai theme ACCELERATING (0.94 conf), Q4 beat + FY27 guide affirmed, dual PT raises to $152/$169, rules 1/3/5/6 firing with Stocktwits velocity flipping to +223% (vs -42% last week). BUT execution is…

Deep-cyclical Brazilian petrochem, NOT a momentum name. Only live angle is the perennial Novonor stake-sale + Braskem Idesa debt-restructuring binary. Nothing accelerating now; the Q1 print (2026-05-13) bounce already faded. Skip until a…

[Stage 1 WATCH] small-cap-ai tag but it''s CPaaS post-Q1 (archetype-5), single B.Riley PT, no chorus, no accelerating narrative leg — RSI 82.5 parabolic momentum reading without a fresh driver.

[Stage 1 WATCH] Autonomous theme NEW but no dossier yet; AUR is cleaner thematic expression with concrete McLane catalyst today

Crypto bull narrative has BROKEN: BTC lost $70K (intraday $65,710 on 2026-06-03), 12 straight days of spot-ETF outflows (~$3.58B), MSTR''s first sale since 2022 killed the perma-bid. A 2x daily-reset ETF near 52-wk lows into a confirmed…

[Stage 1 PRIORITIZE] small-cap-ai ACCEL, cleanest RSI in the cluster (52.8, fully reset), +78.6pp vs SPX, raised guide + Lake St $11; below 52w high (rule 3 fail) caps it to a LOW probe.

Holdco SOTP discount, NOT a momentum setup: BTBT''s $691M mcap is below its 27M-share WYFI stake alone (~$767M at $28.36) plus ~158k ETH (~$330M). But the tape is broken (-25% 12mo, -8.6% on 6/3, $1.85) and the AI-infra momentum lives in…

Oil supply-shock beta: Hormuz still ~closed (7-11 vs ~100 ships/day) keeps WTI ~$90, but the premium is deflating — oil -20% off peak on US-Iran ceasefire optimism. BTE deleveraged to $591M net cash in the windfall, but it''s +198% off…

Broken-IPO falling knife: BTGO down ~69% from its $18 IPO (Jan 2026) to $5.61, sitting on all-time lows after a Q1 EBITDA miss, with a July lockup overhang. Real crypto-custody franchise but dead tape — avoid until a base forms; only live…

Webull is the broken laggard of the prediction-market/retail-brokerage trade — Q1 rev +36% beat (2026-05-21) yet stock sits ~$5.90, ~93% below its 2025 squeeze high and just above the $4.50 ATL. HOOD owns the narrative; BULL has no…

3x leveraged FANG+ ETN — amplified mega-cap AI/tech beta, not a standalone narrative. Trade-able ONLY if NYFANG is trending above rising 20-EMA with VIX<18. Big-tech Q1 earnings cluster (2026-04-22 → 2026-05-02) is the binary; NVDA…

Iran-war/Hormuz freight-spike that drove BWET +725% YTD to $173.78 (5/22) is now DEFLATING on US-Iran ceasefire optimism — oil -20% off peak, fund back to ~$165. SATURATED blow-off (mainstream "1,406%" coverage, lower high vs March…

[Stage 1 DEFER] Biotech archetype-5 binary catalyst with 5/15 extended-FU Phase 3 conference call ~2 trading days out — hard earnings-blackout rule applies, no fresh entries within 3 TD of binary.

Caleres is a tired low-multiple footwear name with no accelerating narrative leg right now — only a speculative "consumer reopening" thread and a binary Q1 print (~late May). Probe-only name unless the print re-rates the brand portfolio…

Not a momentum trade — CCRN is a pinned cash-merger-arb. Aya's $18.61 deal died on FTC antitrust Dec-2025; Knox Lane (PE, no overlap) now buying at $13.25 cash, Q3-2026 close. Stock $13.12 = ~1% gross spread. No narrative leg, capped…

Dormant micro-cap civil contractor just printed a $24M data-center contract (2026-04-09) and got tagged into the M&A/activism/special-sits basket — potential picks-and-shovels + special-sits double-catalyst, but ticker-to-entity mapping,…

Blood-safety turnaround: Q1''26 (4/30) hit adjusted-EBITDA positive (+$4.0M) on +24% product revenue and a raised FY guide ($227–231M), driving a ~2.7x off the $1.15 low. But the re-rate is largely done — MATURING, RSI-overbought near $2.8…

[Stage 1 WATCH] Chip cluster UBS $42 PT, RSI 75 extended, no dossier, negative velocity — cluster covered by stronger held names.

Cannabis-reclassification is ACCELERATING at the policy layer (April Schedule III partial reschedule; DEA broader hearing 2026-06-29), but CGC is a broken-structure value-trap proxy ($1.05, near 52-wk low) carrying a 2026-06-15 earnings…

[Stage 1 WATCH] Thesis broken — Q1 EPS miss + Morgan Stanley PT cut to $12, rule 3 broken (50<200); theme tag by-association only — track for a genuine narrative re-fire, not a buy.

[Stage 1 WATCH] 5 rules + Stocktwits +149% but RSI 77.5 extended, no theme membership, no dossier — single-name chase without cluster edge.

[Stage 1 DEFER] Health-managed-care MATURING, velocity-only setup (Stocktwits +197% with rule_10 attention flat), no cluster confirm — defensive late-cycle rotation

Geopolitical tanker super-spike printing record earnings — VLCC ~$182k/day Q2-to-date (81% fixed) vs $46k 10-yr avg, Q1 EPS $1.27. But it''s a mean-reverting cyclical at a Hormuz-driven peak: stock is ~12% off its high on a blowout Q1, the…

Multi-year Chipotle compounding story has BROKEN: fresh 52-week low 2026-06-03 + Morgan Stanley downgrade to Equal-Weight/$37 same day, on margin compression and a consumer-spending slowdown hitting the whole fast-casual cohort. Dead tape,…

SKIP — dossier-defined invalidation has fired: theme Psychedelic-Mental-Health downgraded ACCELERATING→MATURING, Rule 10 fails, volume collapsed to 0.99x ADV (was 2.83x), StockTwits velocity +367%→+51%. Last news 4/24 FDA voucher cluster;…

[Stage 1 DEFER] Health-managed-care theme conf 0.48 (weakest in set), velocity-only confirm, no dossier — defensive late-cycle rotation, weakest expression of the cluster

Post-fraud holding co (Lugano Diamonds accounting scandal, dividend suspended). Narrative is DEAD, not accelerating. B. Riley Neutral / $10.50 PT on 2026-04-07 caps upside. No momentum setup — SKIP for narrative-momentum book until a clean…

Micro-cap pharma mid-transformation: a $100M Apotex asset-sale (vs $84M cap) re-rated it 3x off $1.85 lows; ifetroban pipeline (Feb-4 DMD Fast Track, Jun-2 metastasis data 0 vs 3 deaths, p=0.037) is the optionality. But the deal is priced,…

[Stage 1 WATCH] Laggard rare-earth name vs MP ([trade redacted] and theme leader); rule_2 edge fails (-1.31pp), no dossier — MP carries the commodity-materials-rare-earths exposure already

Single-asset biotech binary riding a 5-day-old Goldman initiation (Buy, $40 PT, 2026-04-17). Soquelitinib Phase 1 oral-AD readout ~2026-05-12 is the whole trade. No confirming sell-side yet, no pullback. Watch, don't buy — chase risk is…

CRWL is 2x-DAILY CRWD, not an equity. CrowdStrike's business is genuinely ACCELERATING — Q1 FY27 (2026-06-03) printed a 4th straight accelerating revenue quarter (+26%), record net-new ARR ($256M, +32%), raised FY27 guide. But the stock…

[Stage 1 WATCH] Solar-energy-transition new probe theme conf only 0.55 + RSI 76.9 extended + rule 10 fails (attention flat) — first sighting, no comparative edge, wait for theme conviction lift.

Single-asset pediatric-oncology binary: Ojemda (tovorafenib) ramp + FIREFLY-2 front-line pLGG P3 is the whole story. DORMANT tape, no fresh catalyst inside 30d other than ~2026-05-07/14 Q1 print and ASCO 2026 abstract drop — not a…

[Stage 1 WATCH] Resurrected 3D-printing retail narrative, no registry theme, no dossier, RSI 68; no comparative edge vs accelerating clusters — deferred prior, consistent.

[Stage 1 WATCH] RSI 88.6 extreme parabolic with no narrative confirm — rule 5 didn''t fire, late-cycle blowoff in cooling cohort

[Stage 1 WATCH] 5 rules + Stocktwits +196% but no theme membership, first sighting (no dossier), no cluster confirm — single-name retail signal, no edge today.

Regional-bank M&A + rate-cut steepener narrative accelerating under Trump-Bessent OCC; DPST is the 3x leveraged rental on KRE. Q1 regional bank earnings (Apr 22–25) and 2026-05-07 FOMC are the binary catalysts. Decay-prone vehicle — 1–4…

[Stage 1 WATCH] Fresh biotech-precision seed today: RSI 70, Stocktwits +367%, top 1.3% momentum — compelling early narrative but theme MATURING + no dossier; track for theme re-acceleration.

Binary readout ALREADY FIRED: RESTORE-FA topline (2026-05-18) for DT-216P2 gapped +14% then closed -28.88% at $10.22 as open-label n=16 mFARS/biomarker data underwhelmed the run-up toward $17. Narrative leg is SPENT — no hard catalyst for…

Dialysis volume-recovery + GLP-1-fear-reversal re-rate: +70% YTD to ~$195. Q1 beat (adj EPS $2.87 vs $2.33, reported May 5) drove a +27.6% gap and a raised FY guide. But price now sits ABOVE avg analyst PT ($193.71), near ATH ($202.69),…

[Stage 1 WATCH] Space-satellite private-exposure SPAC, no dossier body, Stocktwits +164% — RKLB is the cleaner cluster expression with actual dossier and post-Q1 binary cleared.

[Stage 1 PRIORITIZE] Critical-minerals cluster confirm with held MP: Canadian C$145M govt convertible + IRR raise, theme ACCEL 0.88, Stocktwits +172%, RSI 63.5 healthy, no dossier yet — clean LOW-probe candidate.

[Stage 1 WATCH] Industrial-power-AI cluster duplicate of SHLS but RSI 77 parabolic and theme attention flat — SHLS is the cleaner expression today, consistent with three prior WATCH calls.

RAS-pipeline binary catalyst. ERAS-0015 Ph1 readout narrowed to mid-May 2026 (PR 2026-04-21) stacks with AACR posters 2026-04-25 to 04-30, but the 2026-04-13 -11.52% circuit-breaker halt remains unexplained 9 sessions later. No edge to…

[Stage 1 WATCH] Stocktwits +335% but vol ratio 0.25x (extreme contraction), no dossier, biotech-precision MATURING — single-day flash with no follow-through

[Stage 1 DEFER] Q1 binary (~5/11) already cleared, dossier doesn''t show fresh ignition, CFO transition 6/1 caps conviction — sub-$1B mcap with ADV-driven slippage budget eats edge

[Stage 1 WATCH] small-cap-ai ACCEL but post +85% AH blowoff, rule 3 broken, -94% velocity, no dossier; cluster covered by the cleaner BLZE probe.

Auto-insurance ad-spend recovery supercycle (drove +83% rev Q1'25) has MATURED — Q1'26 rev +15% to $190.9M, three-quarter sequential plateau ~$190M. Stock round-tripped $30→$16.63, bounced to ~$19.40, above 50-DMA but stuck under 200-DMA…

Legacy enterprise-networking name re-rated ~+98% in 3mo on AI-native "Platform ONE/Agent ONE" story + SaaS ARR +29% YoY. Narrative now MATURING: sell-side PTs (~$26) sit BELOW the $28.79 price, insiders selling into 52-wk highs, no…

META AI/superintelligence narrative flipped from accelerating to "show-me-the-margin" after the 2026-04-29 capex raise to $125-145B; META -22% from Aug-2025 ATH, below its 200-DMA, chopping. FBL (1.5x daily-reset ETF) bleeds in this tape —…

AI data-center power narrative (SDCL 450MW LOI, pipeline +275% since Feb '25) drove FCEL +237%/52wk to ~$21.81 — 2.4x the $9 avg analyst PT. Parabolic, low-float, ~7.5% short, now fully binary on the 2026-06-08 Q2 print. Strength is real…

Legacy seat-based CCaaS incumbent racing to out-grow its own AI self-disruption: AI ARR +68% ($125M) but core CCaaS only +8% and total revenue decelerated to +9% (Q1 2026). Stock rolled over $26→$24 (-9% in 3 days), no catalyst until Q2…

[Stage 1 WATCH] space-satellite ACCEL but RSI 81 parabolic, 4 rules, no real dossier; weaker expression than PL — cluster already covered by the PL probe.

[Stage 1 WATCH] Networking-optical post-Q3 record but ''don''t thank Nvidia'' (telecom-driven), edge fails rule_2, negative velocity — COHR/GLW are the held cluster expression.

HBM probe-card picks-and-shovels play into ~2026-05-06 Q1 print. Street PTs raised to $125/$130 (Cantor/B. Riley Apr 2026) but B. Riley simultaneously downgraded to Neutral — re-rate done, guide is the binary. Dormant, no entry without…

[Stage 1 WATCH] Industrial-power new seed, Stocktwits +367% but rule_3 compute failed, options history 1d, no dossier — premature; STRL carries cluster.

[Stage 1 WATCH] Cyber-security-software ACCEL but flagged 15% bid/ask spread + RSI 77 parabolic on 0.76x volume — structurally untradeable today

AI-cyber leg already fired: FTNT +56% YTD to ~$146, Q1 beat (May 6) is 4wks stale, 56.8x P/E, RSI ~80, price ABOVE nearly every analyst PT ($96 fair value, $115 neutral cluster, $150 BTIG bull). CNBC/IBD-retail coverage = late/SATURATED.…

Busted-merger special-sits: Omni deal over-levered FWRD, activists (Ancora, Irenic) forced strategic review, but 18 months on no deal has closed and Stifel just *cut* PT to $30 on 2026-04-16. Narrative velocity is negative, not…

Announced all-cash take-private: Long Lake buys Amex GBT at $9.50/share (~$6.3B), closing 2H 2026, with 69% of holders locked via voting agreements. Stock pinned at ~$9.34 — pure merger-arb, ~1.7% capped upside vs ~36% deal-break tail. No…

Small-cap specialty footwear (Journeys/J&M/Schuh) with a stale reopening tag and no accelerating narrative. Only reason to engage is a binary Q1 FY27 print (~late May 2026) with Journeys comp as the swing variable — otherwise dead tape.

Scheme-of-arrangement casualty. Gold Fields A$3.40 offer for ASX:GOR recommended 2025-05-05, targeted H2 2025 close. Absence of any 2026 news/filings/price signals the ticker is dead. Untradeable placeholder until ASX:GOR listing status is…

2X daily-reset wrapper on Alphabet's accelerating Gemini/Cloud narrative (Q1 Cloud +63%, $460B backlog), but GOOGL is -11% off its 2026-05-13 $402 ATH on the surprise $80B dilution raise — a knife on a leveraged instrument, ~-22% on GGLL.…

[Stage 1 WATCH] AI mag7 MATURING, no dossier, edge +9.3pp barely above floor — mega-cap dilutes alpha on $5k book

Turbo cash-cow repositioning turbomachinery IP into data-center/industrial oil-free cooling (Ingersoll Rand + Trane deals). But the Q1 binary already fired 2026-04-30 (beat + raised guide), popping RSI to ~85 and triggering clustered…

Post-earnings turnaround pop that''s already mature: HELE ran to a 52-wk high $36.58 on the 2026-04-23 Q4 beat but trades ~40-50% above sell-side PTs ($23-25) with RSI 77.7. Catalyst spent, theme MATURING, no fresh accelerating leg to buy.…

3X daily-reset leveraged ETF on the S&P-500 High-Beta basket — a leveraged proxy on the AI risk-on melt-up, not a stock. Regime bullish (S&P record 7,609, GS target 8,000) but entry at [entry redacted] is parabolic: +96% YTD, +38.6% in…

[Stage 1 WATCH] AI-chip missed runner consistent with prior 4 WATCH calls: cluster already covered via TSM/ARM, no 52w-high break, theme MATURING — correlated duplicate, no incremental edge.

BTC-miner→AI-compute pivot: three analyst PT raises in one day (2026-06-03 — B. Riley $8 / HCW $7 / Rosenblatt $5.5) THROUGH a Q4 revenue miss, sell-side starting to price BUZZ HPC, "the growth engine the market is missing." Laggard…

[Stage 1 WATCH] Oil-energy-geopolitical ACCEL but correlated duplicate of WTI with weaker structure (50<200-EMA fails); WTI is the cleaner expression of the same fresh catalyst.

[Stage 1 WATCH] M&A activism theme MATURING (conf 0.62); Q1 FFO beat + FY26 guide raise but theme rolled over with no cluster confirmation — single-name special-sit not narrative-momentum.

CAR-sympathy squeeze setup has cooled into an earnings-binary window: Q1 2026 print ~2026-05-01 is now 5–7 trading days out, theme tagged MATURING, no fresh catalyst. Stay flat; this is a DEFER-into-blackout, not a fresh probe.

Semicap subsystem proxy on 2026 WFE re-acceleration; B. Riley PT $75 (2026-04-13) flags sell-side building conviction, but LRCX print 2026-04-24 is the read-through bomb and ICHR's own Q1 (~2026-05-07) is a hard binary. DORMANT until one…

M&A special-sit just broke: SiriusXM merger talks iced 2026-05-29 over a station-divestiture/antitrust impasse; the $6.56 deal-spec spike has fully round-tripped to ~$4.30. No accelerating narrative left — 5.5x-levered radio name with Adj…

Genomics-monopoly turnaround that has already worked: ILMN ~doubled YTD on a clinical-sequencing inflection + NovaSeq X ramp + buybacks, now pinned at 52w highs ($175.73) trading ABOVE the $138 avg analyst PT. MATURING/recognition phase —…

Automotive ADAS-silicon design-win story improving — $7.4B backlog, $25M 77GHz radar order, NIO vision ramp (Q1 print 2026-05-07). But Q1 rev only +3% YoY, deep $38.9M GAAP op loss, Q2 growth partly Wuxi-consolidation, and next catalyst…

Satellite-comms regulatory tailwind (FCC spectrum-sharing 7x capacity) + bullish $40 call sweep into Q1 earnings 2026-04-23 BMO. Binary print in 3 trading days = DEFER; fresh entry only on post-earnings reaction, not pre-print.

Broken-chart specialty GI biotech — Linzess royalty bleeding from Part D redesign, apraglutide SBS-IF PDUFA is the only narrative leg. Binary catalyst, not momentum. SKIP until fresh price structure or positive FDA signal re-fires the tape.

Distressed legacy carrier: CEO forced to publicly deny bankruptcy (2026-04-20 Bloomberg) while Spirit teeters and Duffy teases airline M&A. Binary Q1 print in ~1-2 weeks decides whether this becomes a Spirit-exit + takeout squeeze or a…

Aluminum tariff supply-shock + Q1 earnings inflection drove KALU +156% YoY to ATHs ($186 vs $194 high), but the clean leg ran Feb–Apr: earnings printed 4/22, sell-side already upgraded, price now ABOVE the highest PT ($183) with no…

KALV is in a $27.00/share all-cash takeout by Chiesi (announced 2026-04-29); tender expires 2026-06-10, close expected Q3 2026. Stock pinned at $26.95 — ~0.2% spread up vs ~40% deal-break downside. Narrative fully monetized into the deal;…

Staffing-cycle inflection: KFRC returned to YoY revenue growth Q1 (2026-04-27, EPS +18% beat, +17-20% pop) after a 2-yr decline, raised Q2 to ~$348M (+4% YoY), AI/data consulting pipeline +50%. Real recovery but low-beta income name, no…

Dormant legacy shell with two live binaries: ~$530M KRIP pension reversion (H1 2026) and Rochester REE/pharma pivot. Q1 2026 print ~2026-05-08 is the window — blackout kicks in ~2026-05-05. Narrative is NOT accelerating on KODK…

Post-2026-04-08 ceasefire energy gap likely broke structure; ~2026-05-05 Q1 2026 print is the binary — need GTA cargo count ≥2 and net debt down >$150M QoQ before any long. No pre-earnings edge on a 2.5–3x levered E&P.

3x leveraged biotech ETF (tracks XBI basket). Sector has been DORMANT for 3 years; setup requires XBI to break 50-day high on volume + dovish Fed + M&A acceleration off the patent-cliff. Without that ignition, LABU just bleeds from…

AI-insurtech IPO (Ethos) — Q1 rev +104% to $193M + raised FY guide drove the pop, but Bear Cave's 2026-05-21 report alleging aggressive upfront commission accounting put the narrative on trial. Battleground, not a clean trend; wait for…

AI-native insurtech with accelerating fundamentals (loss ratio 62% vs 78% YoY, Adj-EBITDA+ guided Q4''26, Tesla FSD auto-insurance leg) but a BROKEN tape: beat-and-raise on 2026-04-29 was sold, price rolled -40% to ~$53 on the $50 H&S…

Post-earnings (2026-04-14) digestion still unresolved without price refresh. LOVE only matters as an a6 squeeze on a beat+raise tape against a graveyard furniture sub-sector, or as a deferred a5 pullback retest. Binary catalyst window…

[Stage 1 WATCH] Space basket beta with no dossier and SpaceX-IPO halo only — RKLB stop-out frees no slot, no comparative edge

Bitcoin-miner-to-AI-pivot story, but the core is on fire: BTC crashed to $63.7K (June 4) and the 2026-06-02 Q1 was a double-miss (rev $174.6M -18%, -$1.3B net loss on a $1B BTC writedown). The Starwood 1GW→2.5GW AI/HPC leg is a promise,…

[Stage 1 WATCH] RSI 88.7 extreme, no theme, no dossier, +107pp vs SPX on first sighting — no cluster context, no fundamental tether; classic late-stage blowoff trap.

METU is 2x-leveraged META. Q1 beat (rev $56.3B, +33% YoY, EPS $7.31) but the $125–145B capex raise gapped META ~6% on 2026-04-29; now basing/recovering toward ~$615. Narrative intact but MATURING and in digestion — the wrong tape for a 2x…

⚠️ MNMD no longer trades — rebranded to Definium (DFTX) on 2026-01-15; MM120→DT120. Pure binary-catalyst psychedelic name: EMERGE (LSD in MDD) Phase 3 topline lands ~late Q2 2026, ~3 weeks out. Stock +20% into the print at ~$25 — a…

[Stage 1 DEFER] Strong 6-rule industrial-power-AI name (RSI 60, top momentum) but Q4 FY26 prints TODAY 2026-05-26 after close — deep in earnings blackout, binary risk forbids fresh entry.

Managed-care trough-year rotation: MOH reset FY26 adj-EPS to ≥$5.00 (Feb -28%), then Q1 beat at $2.35 / MCR 91.1% and reaffirmed (late Apr, +9–17%) — first sign Medicaid cost trend is stabilizing. But stock is +58% off the $121 low and…

[Stage 1 WATCH] small-cap-ai ACCEL but mid-parabolic digestion of a +131%/30d runner, rule 3 broken, no dossier; W20/W21 postmortems explicitly flagged this archetype as a chase trap.

Post-COVID turnaround re-rating: MRVI ($1.99 low) is at a fresh 52-wk high $5.16 after the Q1 beat (rev $65.8M vs $52.9M est, +41% YoY) + FY26 guide raise + the 2026-06-02/03 refi that cut debt $243M→$150M and killed the balance-sheet bear…

[Stage 1 DEFER] Earnings tonight 4/29 AMC — inside earnings blackout; theme MATURING (AI Mag-7 platforms); RSI 74 extended on momentum-only setup with empty dossier.

Second-derivative recovery: broadband CPE trough + AsterionX 800G optical DSP optionality into AI backplanes. Binary on Q1 FY26 print (~2026-04-28). Pre-earnings, within 3-day blackout window — no fresh entry.

Pure high-beta oil-war-premium proxy: +90% YTD on the US/Israel-Iran war (Brent ~$100) + Q1 beat + sell-side PT hikes to $115-120. But at ~$100 near its 52-wk high ($105.80) it''s MATURING/late — the war premium is mainstream and fully…

Rare limit-up halt +9.30% on 2026-04-15 after Citi PT raise to $12.50 (2026-04-14) flipped NEXA from high-cost zinc laggard to Aripuanã-ramp + copper-optionality play. Binary Q1 production report due ~2026-04-28 to 2026-05-02 is the only…

Beaten-down legacy brand at 52-wk lows (~$43.38, -25% in 3mo); the May rate-relief bounce FAILED into a lower low. Elliott Hill turnaround is unproven and price structure is broken — a falling knife into the binary 2026-06-30 Q4 print. No…

[Stage 1 WATCH] Stocktwits +367% spike but no registry theme membership, no dossier, no comparative edge vs cluster-confirmed names — pure retail-velocity signal.

Oil-geopolitical risk-premium narrative cooled from ACCELERATING (5/19) to MATURING (5/21). NRGU is a 3x DAILY-leveraged big-oil ETN that bleeds in chop. No confirmed fresh accelerating leg, no live oil tape — LOW-conviction probe only;…

Beaten-down TTFields oncology-device name (~$12, just above 52-wk low $9.82) that round-tripped its Feb Optune Pax approval; the ONLY near-term re-rate is the binary Phase 3 TRIDENT GBM overall-survival readout due by end of Q2 2026.…

[Stage 1 WATCH] 2x leveraged NVDA — correlated duplicate; if the synthesis approves NVDA exposure, take it via NVDA/TSM not levered ETF in NEUTRAL regime.

Water-infra + precast roll-up legacy-pivot; +190% over 52wks on record Q1 backlog ($373M WTS) and a ~90% EPS beat (Apr 29). But MATURING — at 52w highs, ~20% above the $99 analyst-PT cluster, next catalyst (Q2) ~7 weeks out. Fresh entry at…

3x leveraged E&P ETN — a tactical/catalyst vehicle, not a hold. No live oil catalyst, no price confirmation, and theme is MATURING (2026-05-20), so it's a decaying instrument with no trend to ride. Probe only on a confirmed crude breakout…

Broken-IPO turnaround with zero narrative acceleration — 4 straight YoY-decline quarters, TikTok brand damage persisting, K18/private-label stealing shelf. New CEO Baldwin 2 years in, no inflection printed. DORMANT until Q1 2026…

Both binary catalysts already fired: Novo Nordisk $2.1B zaltenibart deal (closed 2025-12-01, $240M cash) and FDA approval of YARTEMLEA for TA-TMA (2025-12-23). Now a launch-ramp story one quarter in (Q1 net sales $9.9M). Stock $10.74, -39%…

Drone-dominance policy trade ACCELERATING (Pentagon push + Trump equity-stake rumor 2026-05-28); ONDS riding it on $110M Q2 bookings (2026-06-01) + World View Navy ISR win (2026-06-02). But it's the most-diluted retail vehicle in the…

Russell 3000 index-inclusion flow (effective 2026-06-26) plus CEO Nejatian's warrant short-trap are squeezing the tape into a known date, but it's a fully-telegraphed flow event on a deteriorating iBuyer (Q1 rev -38% YoY, Q2 guide a ~20%…

Pre-revenue long-acting psoriasis biologic story with 6 sell-side upgrades in 9 days (Apr 6–15 2026) and zero corroborating filings — textbook pre-offering setup, not a clean narrative leg. Wait for either an S-3 print (thesis kill) or a…

[Stage 1 DEFER] Health-managed-care MATURING; Q1 cleared with only Equal-Weight/Neutral PT bumps (Barclays $21, Baird $19, Wolfe PP) — defensive rotation not narrative momentum

Beaten-down premium resort-wear holdco (Tommy Bahama, Lilly Pulitzer) in a multi-quarter declining-comp tape. "Consumer-reopening" theme is 4+ years stale; narrative velocity is zero. Classic value-trap silhouette — cheap multiple plus…

Megacap cyber leader printed a clean Q3 beat (rev +31%, NGS ARR +60% to $8.13B, 2026-06-02) but SOLD the news -6% off the $300 ATH while ~20 sell-side desks raised PTs the same day (2026-06-03) — textbook late-stage, sell-side-caught-up…

Eligible on paper (rank 6/3824, +61pp vs SPX 20d, RSI 62, WSB velocity +250%, short interest 32.8%) but the dossier is unambiguous: this is a micro-cap binary ~15 calendar days from the 2026-05-07 Q1 print that must quantify the Medicare…

Activist turnaround (Hestia''s Kurt Wolf now CEO) has largely PLAYED OUT: ~3x off the $8.95 low to a 52-wk high $17.09 on buybacks (17.2M sh/$186M YTD), cost cuts and debt paydown. Q1 (reported May 5) raised FY26 guide but revenue still…

[Stage 1 WATCH] small-cap-ai ACCEL but rule 3 broken (50<200), RSI 78 parabolic, negative velocity, no dossier; correlated chase-dup of held WEST — deferred 4x.

[Stage 1 WATCH] small-cap-ai tag but special-sit M&A thesis 18mo stale (SKT convertible), Barclays cut to Equal-Weight; RSI 83 parabolic — momentum without a fresh narrative driver.

Powersports turnaround inflecting — Indian Motorcycle sold to Carolwood (closed 2026-02-02), Q1 (2026-04-27) printed first positive adj EPS (+$0.13 vs −$0.90) on +423bps gross margin. But the recovery leg ($52→$64) has mostly played;…

Grid + AI-datacenter power buildout ACCELERATING; PLPC a real 2nd-order beneficiary but the stock front-ran it — $387.69 (2026-06-04), fresh ATH $391.40 THROUGH old 52w high $371.80, on a Q1 revenue MISS + Freedom Broker downgrade.…

Hydrogen-comeback + margin-turnaround squeeze already ran +475% off the $0.69 low to ~$3.57; the Q1 beat (2026-05-11) is behind us and price sits at the $3.75 Susquehanna PT. Fresh entry now chases peak-retail on a serial diluter — only…

Former ultra-low-float Permian E&P squeeze rolling over — $181 on 2026-06-04, down ~20% from March $227; Q1 (5/20) net income halved to $4.3M with NEGATIVE realized Permian gas (-$0.40/Mcf). No AI here (theme tag is a misclassification).…

MRD/liquid-biopsy narrative accelerating: 4 Medicare wins (May 13/19) + best-in-class ASCO data (May 29-Jun 2) drove a +70% 2-week vertical. But those catalysts already fired — a fresh entry at ~[entry redacted] just under the $11.85…

Natural-gas rig-reactivation thesis: LNG ramp + AI data-center power demand should pull gas-directed drilling higher in 2H26, with PTEN''s 100% gas-powered frac fleets + capital returns as leverage. But it''s a slow-burn cyclical — Q1 was…

DORMANT / avoid-long into Q1 FY26 print. LVMH 2026-04-13 miss (€19.12B vs €19.49B est) plus "fall off a cliff Q2" sell-side piece put mid-tier apparel in the crosshairs. No PVH-specific catalyst within 30d; binary is the…

Narrative still broken post-2026-05-05 Q1 (Q2 transaction-margin dollars guided to DECLINE); price stuck below 50/200-day in a death-cross. The 2026-05-29 "beaten-down bounceback" media chatter is bottom-fishing, not a momentum leg.…

[Stage 1 WATCH] Merger-arb (SWKS buying $32.50 + 0.96sh), upside capped at deal value, downside binary on deal-break; the 52w-high/RSI signals are SWKS artifacts — outside the momentum edge.

eFPGA/defense-chiplet IP-royalty narrative accelerating (record $168M funnel, four Intel 18A wins, RadPro rad-hard silicon); 2026-06-29 Russell 2000/3000 inclusion is the near-term passive-bid catalyst — but it's a low-float microcap…

FDA-regime-change relief rally: Makary''s 2026-05-12 ouster revived hope the FDA reverses its March rejection of AMT-130''s accelerated path; +47% in 30d (to ~$30) into the 2026-06-18 AMT-260 epilepsy readout. Speculative recovery into…

RAMP signed an all-cash takeout by Publicis at $38.50/share (announced 2026-05-17, 29.8% premium). Stock gapped to the cap and now trades as a merger-arb stub — no narrative leg, upside hard-capped, closes by end-2026. The "momentum score…

RAP-219 Phase 2a FOS data (77.8% median seizure reduction, Dec 2025) pulled Phase 3 forward to Q2 2026 and drove a 5× rally to $39.71; AAN 8-wk follow-up podium on 2026-04-21 is a binary inside 24h, and current price is 6% below 52-wk high…

[Stage 1 WATCH] Q1 miss + $350M dilutive offering announced 5/6 broke the thesis; sliding tape since, no dossier — narrative-broken, track for new setup not entry.

Binary-catalyst precision oncology setup into ASCO 2026 abstract titles (2026-05-23) and Q1 print (~2026-05-07). Split sell-side ($18 Jones Hold vs. $21 Barclays OW) = undecided market; RLY-2608 PI3Kα breast cancer data is the only thing…

Post-blowup CNS microcap in dead zone — no dated Phase 2b Sepranolone or RELIGHT readout inside 30 days. Only near-term event is the ~2026-05-15 Q1 10-Q, which is an ATM/runway reveal, not a thesis-igniter. DORMANT: watchlist only, no…

Reverse-merger special situation, NOT a momentum trade. RLYB shell popped +19% to $17.25 on 2026-06-01 Avenzo oncology merger + $215M PIPE (combined co. = AVZO, closes Q4 2026). Legacy holders get cash distribution + CVR + thin 2.8% stub;…

M&A pop is over. Real Brokerage's all-but-stock takeover (announced 4/27, $13.80 headline) is now worth only ~$9.3 blended because acquirer REAX fell to $1.66. RMAX trades at parity ($9.08) with ~34% downside on a break — a thin arb on a…

Leveraged 2x AI/tech beta in a parabolic, accelerating tape — ROM +42% in a month, +110% 1yr, broke ATH $171 on 06/03. Narrative is real (Vera Rubin in production, Dell +88% YoY) but price is blowoff-extended ~15% above MA and reversed…

Two-activist special sit: Forager $4.80 non-binding cash bid (2026-04-17) + Veradace open letter (2026-04-09) pressing RPAY to abandon KUBRA deal and sell. Poison pill adopted 2026-04-14. Binary arb setup — topped bid to $5.25+ vs…

Ticker "RPI" does not resolve to a live US-listed equity as of 2026-04-20 — legacy Roper Industries symbol (now ROP) and no viable successor. Zero price, news, filings. Not tradable; archive unless Christoph reconfirms the intended name.

AI-neocloud pivot accelerating: $270M Blackwell B300 GPU contract (2026-06-04, largest ever) + Northern Data''s 22,400 GPUs closing mid-June + hyperscaler-compete cloud launch. But tape just printed +26%→+5.5% spike-and-fade near 52w highs…

Asset-light freight broker sitting at the intersection of (a) late-stage freight recession inflection and (b) consolidation/activist chatter post-Coyote integration; Q1 print (~2026-05-06) is the binary — either gross margin expansion…

SentinelOne busted post Q1 FY2027 — stock cratered 2026-05-28 on an affirm-not-raise guide ($1.195-1.205B rev vs $1.206B est) plus 8% layoffs/$25M charge; analyst wall split $15-$24 with no direction. Broken momentum, not an accelerating…

Beaten-down legacy GDS re-rating off the $0.81 low on a deleveraging turnaround — Q1 (5/7) beat (rev +8%, EBITDA +21%), maturity wall pushed to 2029+, 12.4% [trade redacted] YoY) = squeeze fuel; SabreMosaic AI airline-retailing is the…

[Stage 1 WATCH] EMS chip-adjacent post-Q2 beat, RSI 83 parabolic, no dossier — cluster covered by larger names

[Stage 1 WATCH] Space-satellite ACCEL but no dossier, $12M Greek contract isolated headline — RKLB carries the cluster

[Stage 1 WATCH] fintech, rule 3 broken (below 52w high), crypto-financials theme MATURING, no current theme membership/dossier — no cluster confirm, retail-velocity only.

Beaten-down fast-casual turnaround: JPM''s contrarian Overweight ($13 PT, 2026-05-22) plus the Wraps/Infinite-Kitchen story drove a +39% YTD bounce to ~$9.63, but Q1 comps [trade redacted] and the next proof point isn''t until the Aug 6…

[Stage 1 PRIORITIZE] [trade redacted], biotech-precision ACCELERATING with rules 1/2/4/6/10 firing but RSI 74.5 extended — empty dossier and ANAB outpacing means Stage 2 must decide hold vs trim vs rotation.

Tariff-recovery ("worst is behind us") narrative is PLAYED OUT, not accelerating: SHOO round-tripped $22→$44 and now sits ON the $43.88 consensus PT. Q1 +18% rev is Kurt Geiger M&A; organic DTC only +8% and adjusted EPS FELL to $0.45 from…

SpaceX-IPO proxy mania drove SIDU vertical into late May; mgmt cashed the hype with a $100M direct offering at $5.08 (2026-05-28) — textbook distribution top-tick. Retail-squeeze name on $359K quarterly revenue. No fresh-entry edge;…

[Stage 1 WATCH] MEMS-timing picks-and-shovels Stifel $500 PT; RSI 76.6 extended, top 0.3% momentum but cluster covered by GFS/ARM PRIORITIZE picks

No tradeable narrative. SIVEF remains an unresolved F-suffix OTC ticker from 2026-04-18 Serenity seed — issuer still not mapped to a US-tradable equity after one week. Research-blocked; do not size.

Korea-ceasefire re-rating + AI-telco (Anthropic-backed "A." assistant) narrative in play, but SKM is a 0.4-beta dividend telecom — wrong vehicle for narrative-momentum book. EWY is the cleaner expression. Watchlist only; Q1 print…

Pure merger-arb, narrative-dead. NBIX $53.00 cash deal announced 2026-04-06; 5 sell-side desks collapsed PTs to exactly $53 within 8 trading days. Sub-1% spread vs -35% break tail — wrong archetype for narrative-momentum book. Skip unless…

[Stage 1 WATCH] biotech-precision MATURING (rule 10 fails), RSI 73 + retail-distribution blowoff pattern, no named clinical catalyst — deferred 3x consistently; track for a milestone or theme re-accel.

May margin-recovery rip (+68%) off the Q3 FY26 beat is rolling over — two distribution days, price back at the 50-DMA (~$47.5), Mizuho PT $44 below spot, first leveraged SMCI ETF launched 6/1 = late-stage retail saturation. Faded…

New position, not held. Rules 1/2/4/5/6 fire on momentum (rank 35/3824, +45pp vs SPX 20d, 1.76x vol, RSI 70.8, StockTwits +193% 3d/14d) and theme is ACCELERATING, but dossier discipline is explicit: archetype-5 single-asset binary on…

[Stage 1 DEFER] CFO exit + 16% layoffs + analyst PT dispersion $5.25-$15 = restructuring story, not narrative-momentum; theme MATURING — off-playbook regardless of momentum rank

StoneX is a quiet legacy FCM/brokerage compounder with thin digital-asset optionality; no accelerating narrative right now and bearish 2026-04-16 "stocks to dump" mention. DORMANT — no fresh entry thesis into ~2026-05-07 fiscal-Q2 print.

[Stage 1 WATCH] 3x leveraged semi ETF, decay risk on parabolic leg, chip exposure already covered via held NVDA/TSM — redundant beta.

[Stage 1 WATCH] space-satellite ACCEL but only 4 rules, no dossier, weakest space expression; PL carries the cluster probe.

Post-Alcon-break special situation: shareholders killed the $30.75 takeout (Jan 6 2026); Broadwood (31%) now on the board pushing a standalone ~$50 path. China ICL recovery is real (Q1 rev +120%, EPS $0.29 vs $0.08e) but the tape already…

Cyclical semi laggard 4 trading days from Q1 2026 binary (2026-04-24). Mizuho Outperform/PT $48 upgrade 2026-04-17 marks sell-side capitulation end, but entering pre-print is gambling, not edge. DEFER until post-earnings tape confirms auto…

[Stage 1 DEFER] Q3 FY26 earnings ~4/29 (1 trading day), RSI 78.2 extreme, sell-side now chasing ($582→$595→$605 in 14d) = late-cycle distribution setup; dossier mandates DEFER through print.

Coal-policy sympathy squeeze: SXC ripped ~+70% off lows to a 52-wk high on Trump''s 2026-06-03 $700M coal push, but RSI ~80 and that funding hits an Oakland terminal + thermal plants, not SXC''s met-coke core. Extended +34% over the…

[Stage 1 WATCH] RSI 77 parabolic chip cluster name, no synthesis, negative velocity — correlated dup of cluster picks already prioritized.

Legacy open-web ad network repricing as an agentic-AI ad platform (Realize+ + Claude Skills, launched 2026-04-23) on a Q1 beat-and-raise (2026-05-07). But only ~6% revenue growth and a ~$77M one-time legal windfall flatter the print.…

Closed all-cash merger, not a momentum trade: IKS Health buying TBRG at $26.25 cash (signed 2026-04-23), stock pinned ~$25.85 = ~1.5% gross spread to an expected Q3 2026 close, ~27% of shares locked to vote yes. Narrative leg already…

Semicap-test pure-play with clustered analyst PT raises ($400–$415) into a binary Q1 print window ~2026-04-22 to 2026-04-24. DORMANT in the 72h earnings blackout; post-print reaction bar decides if this goes ACTIVE long or gets skipped on…

Small-cap workforce-housing re-rate setup: two Street PT hikes in 72h (Stifel $15 2026-04-06, Oppenheimer $18 2026-04-09) front-running a contract-award or Q1 beat. Binary catalyst — ~2026-05-07 Q1 print + any 8-K contract headline is the…

Cannabis Schedule-III reform trade back on into the 2026-06-29 DEA adult-use rescheduling hearing; sector re-accelerating but TLRY chart is busted — ~$5.12, below 200d, near 52-wk low after round-tripping $23→[entry redacted]…

Binary PRMT5i catalyst: TNG462 AACR 2026 poster drops between Apr 25–30 (abstracts Apr 21–23), repricing the stock ±30–60% in one session. No tape confirmation, no pre-data accumulation signal validated — stays DORMANT/LOW until structure…

Value-based oncology turnaround inflecting to first-ever profitability: Q1''26 revenue +41% YoY, Florida capitation turned profit, FY26 adj-EBITDA guide raised to $0–9M. Stock tripled off $2.02 low; today''s +12.4% squeezes an 11% short…

Cash-rich Panagiotidis shipping shell (NOT lawnmower-maker TTC) already ran 1.93→8.50 (~4.4x) on special-dividend/discount-to-NAV closing; now ~$5.22, −39% from high, trading ABOVE liquidation value. $0.90 special div already went ex.…

[Stage 1 WATCH] 3x leveraged Nasdaq ETF; rule 10 fails on attention flat + chip cluster covered by direct names; decay risk

Post-offering digestion at $13.00 anchor ahead of mid-2026 Phase 2b RIVER topline (chronic cough in IPF). Dilution overhang priced in but no clean base yet — DORMANT pending 3 closes above $13.50 on fading volume. Archetype-5 binary,…

TSLA robotaxi/autonomy narrative had its ACCELERATING leg in May (+14% to a May-11 peak), then stalled when fleet expansion froze (May 10) and SpaceX-IPO dilution fears hit (-6.5% into June). TSLL is the 2x proxy, but in this chop…

TSLR is a 2x daily-reset leverage wrapper on TSLA — trading the robotaxi/autonomy narrative with a 2x amplifier plus a decay tax. TSLA (~$419, 2026-06-03) rallied through May on robotaxi + SpaceX-IPO buzz but stalled at $450; RSI ~53…

FILSPARI FSGS approval fired 2026-04-14 with 6 same-day PT hikes ($44–$56); T+8 sessions into post-binary drift window. DORMANT until either a weekly close above 2026-04-14 gap-high on >1.5x volume (breakout entry) OR Q1 print…

Legacy single-cell franchise pivoting to spatial biology with 2026-04-20 Atera launch + clustered sell-side PT raises ($24→$30→$32). Narrative is nascent, not accelerating; price structure still multi-year downtrend. Probe only on…

Second-order semicap play on LRCX/AMAT WFE spend (~70% customer concentration). Thesis is structurally intact (HBM capex, Products GM recovery) but tactically locked out — LRCX prints 2026-04-23 AMC and UCTT prints ~2026-04-29, both inside…

Legacy #3 mature-node foundry grinding to a 52-wk high (2026-05-27) on the Intel 12nm Arizona JV (2027 prod) + first-ever 14nm FinFET display-driver platform (2026-05-14). Real pivot, but a slow low-beta ADR — catalyst is years out and…

2x daily-reset leveraged proxy on UnitedHealth's managed-care margin recovery. UNH +~50% off 2025 crash lows to $377 (2026-06-03), but the easy leg is spent — avg analyst PT $404 sits at spot, Berkshire fully exited May-2026, DOJ probe…

Post-Windstream merger fiber REIT with 47% analyst PT spread (RBC $7.50 vs Barclays $11, both mid-April 2026). Archetype-5 binary: Q1 2026 print ~May 6–9 is the only thing that matters. DORMANT until that tape resolves deleveraging pace…

2x-leveraged semis basket on the AI-chip buildout: fundamentals ripping (WW semi rev +79% YoY, AVGO AI +143% in the June-3 print) but the tape is digesting AVGO''s "beat-but-no-FY27-guide-raise" sell-the-news while SOXX sits overbought.…

Long-oil geopolitical premium (USO) is SATURATED at a binary inflection: Iran exports at a 6-yr low + summer-squeeze warnings keep it bid, but the pending US–Iran 4-stage deal explicitly lifts oil restrictions — the most likely near-term…

Picks-and-shovels semicap into AI capex: Q1 (2026-05-05) double-missed but stock gapped +21% on a >$250M multi-customer order book + affirmed FY26 sales guide above consensus. Recovery-not-acceleration story; the +21% pop is ~a month stale…

[Stage 1 WATCH] T&M laggard sleeve already +25% post-Q3 beat with 4 PT raises; archive shows 5+ consecutive DEFER sessions, GLW/COHR carry the optical cluster cleanly. Consistency is edge.

[Stage 1 WATCH] industrial-power-AI fundamentals accelerate (backlog $301M) but pivot-top sell signal 5/11 + 192 insider sells / 0 buys; broken price structure — track for a $300 reclaim, don''t catch the knife.

Post-COVID biotech pivot — VIR-5500 Phase 1 (PSMA dual-masked TCE) first patient dosed 2026-04-13; AACR 2026-04-25→30 posters and Q1 2026 earnings (~early May) are the next binary inflections. DORMANT until first-cohort safety disclosure…

[Stage 1 WATCH] Industrial-power-AI #2 — secondary to VRT in same theme; RSI 74.9 extended, vol only 0.60x, no built dossier; only relevant on relative-strength signal vs VRT.

[Stage 1 PRIORITIZE] analog-components 3rd cluster confirmer, 5 rules, +102.5pp vs SPX; RSI 84.7 parabolic + no dossier ranks it behind QCOM/SIMO — LOW probe, not benched (accelerating cluster name).

[Stage 1 WATCH] Mis-tagged: dossier explicitly says zero AI/HBM exposure, analog auto-cycle name, archetype-5 binary cleared without conviction — not a narrative-momentum trade.

Pure-play HDD picks-and-shovels leg of AI data-infra; sell-side drift up (Citi $405, MS $380) into fiscal Q3 print ~2026-04-29/05-01. Stock is in the Hormuz-rally cohort so materially extended — the print + MSFT/META/AMZN capex guides in…

WLAC de-SPAC''d into Boost Run (NASDAQ: BRUN), an NVIDIA-certified GPU neocloud that doubled in 30 days on $940M contracted revenue, a $1.44B Dell deal (4/22) and a $471.7M Thinking Machines contract. Narrative ACCELERATING, but entry is…

[Stage 1 WATCH] small-cap-ai ACCEL but RSI 83 parabolic (most extended in cluster), no dossier, correlated dup; consistent with 4 prior WATCH calls.

Activist-catalyzed distressed turnaround: STARTEEPO Invest lifted its stake to >6% (3rd-largest holder, 13D/A 2026-06-01) on a Lexmark-synergy + deleveraging bet. Stock +193% off the $1.19 low to ~$3.49 — but it''s a 7x-levered net-loss…

Memory super-cycle + rally broadening beyond mega-caps is XSD''s leg: modified-equal-weight tilts to MaxLinear/Astera/Navitas/Marvell, not NVDA. But fresh entry at the 52-wk high ([entry redacted]) into SMH weekly RSI>80 (all-time, 5th…

Not a momentum setup — a binary Nasdaq delisting/shell rescue. XTLB ($5.6M cap, $2.23, at 52-wk low) is a public shell on a conditional listing exception; must close the Psyga Bio reverse-merger + $1.5M raise and regain full compliance by…

Bitcoin-treasury proxy thesis is BROKEN: mNAV collapsed to ~0.68x diluted — XXI trades BELOW its own BTC NAV, killing the accretive equity flywheel. BTC dumping ~13%/week, stock pinned at all-time low $5.61. Falling knife in a…

April AI-partnership squeeze (+56% to $1.77 on 2026-04-27 YATOP deal) has fully roundtripped; now a sub-$1 China SaaS nano-cap ($0.94, 2026-06-04) at 52-wk lows with a 11.1M-share resale overhang (~49% of float) and live Nasdaq delisting…